Krzysztof Selmaj Selected Research

Krzysztof Selmaj Research Topics

Disease

45	Multiple Sclerosis 03/2022 - 01/2002
26	Relapsing-Remitting Multiple Sclerosis 10/2020 - 11/2003
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2014 - 12/2002
4	Neoplasms (Cancer) 01/2017 - 01/2006
3	Inflammation (Inflammations) 03/2022 - 12/2002
3	Atrophy 03/2022 - 10/2008
3	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 02/2008
3	Infections 01/2017 - 10/2015
3	Necrosis 01/2006 - 11/2002
2	Neuromyelitis Optica (Devic's Disease) 01/2021 - 07/2013
2	Exanthema (Rash) 10/2015 - 06/2013
2	Flushing 09/2015 - 09/2012
1	COVID-19 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 10/2021
1	Cytopenia 10/2021
1	Splenomegaly 10/2021
1	Hypertriglyceridemia 10/2021
1	Fever (Fevers) 10/2021
1	Chronic Progressive Multiple Sclerosis 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Congenital Heart Defects (Congenital Heart Defect) 12/2016
1	Spontaneous Abortion (Miscarriage) 12/2016
1	Transposition of Great Vessels (Great Vessels Transposition) 12/2016
1	Ulcerative Colitis 07/2016
1	Urinary Tract Infections (Urinary Tract Infection) 07/2016
1	Pneumonia (Pneumonitis) 07/2016
1	Injection Site Reaction 12/2015
1	Eczema 10/2015
1	Autoimmune Hepatitis 05/2014
1	Psoas Abscess 06/2013
1	Nausea 09/2012
1	Abdominal Pain (Pain, Abdominal) 09/2012
1	Diarrhea 09/2012
1	Hypoglycemia (Reactive Hypoglycemia) 10/2010
1	Uremia 10/2010
1	Diabetic Angiopathies (Diabetic Angiopathy) 10/2010
1	Acidosis 10/2010
1	Hypertension (High Blood Pressure) 02/2010
1	Atrioventricular Block 02/2010
1	Macular Edema 02/2010
1	Bradycardia 02/2010
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 08/2008

Drug/Important Bio-Agent (IBA)

10	Dimethyl FumarateIBA 01/2022 - 09/2012
7	Interferon beta-1a FDA Link 01/2018 - 11/2003
5	Glatiramer Acetate (Copaxone)FDA Link 10/2021 - 05/2006
5	Daclizumab (Zenapax)FDA Link 10/2020 - 06/2013
5	AntigensIBA 03/2015 - 06/2004
4	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 02/2010
4	ocrelizumabIBA 10/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2007
4	GadoliniumIBA 01/2018 - 09/2014
4	Peptides (Polypeptides)IBA 10/2014 - 10/2007
3	daclizumab HYPIBA 10/2015 - 06/2013
3	InterferonsIBA 11/2014 - 05/2006
3	LigandsIBA 01/2010 - 11/2002
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2008 - 12/2005
2	teriflunomideIBA 01/2022 - 01/2020
2	AntibodiesIBA 01/2021 - 10/2017
2	FumaratesIBA 01/2020 - 02/2014
2	siponimodIBA 09/2016 - 08/2013
2	EnzymesIBA 07/2016 - 02/2010
2	Transaminases (Aminotransferases)IBA 10/2015 - 09/2012
2	Notch ReceptorsIBA 01/2010 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 01/2008 - 09/2004
2	ChemokinesIBA 09/2004 - 12/2002
1	temelimabIBA 03/2022
1	TabletsIBA 01/2022
1	Cladribine FDA LinkGeneric 01/2022
1	Ferritins (Ferritin)IBA 10/2021
1	Biological ProductsIBA 01/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021
1	ofatumumab FDA Link 01/2020
1	diroximel fumarateIBA 01/2020
1	Cytidine Diphosphate (CDP)IBA 12/2018
1	LipidsIBA 10/2017
1	CholesterolIBA 10/2017
1	Lisinopril (Prinivil)FDA LinkGeneric 12/2016
1	Neuroprotective AgentsIBA 06/2016
1	Generic DrugsIBA 12/2015
1	Pharmaceutical PreparationsIBA 12/2015
1	Interleukin-2 (IL2)IBA 10/2015
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 03/2015
1	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2015
1	Indicators and Reagents (Reagents)IBA 12/2014
1	Chemokine ReceptorsIBA 11/2014
1	Therapeutic UsesIBA 08/2013
1	Natalizumab (Tysabri)FDA Link 07/2013
1	Interferon-betaIBA 04/2011
1	Glucose (Dextrose)FDA LinkGeneric 10/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2010
1	Uremic ToxinsIBA 10/2010
1	Alemtuzumab (Campath)FDA Link 08/2010
1	Monoclonal AntibodiesIBA 08/2010
1	Retinaldehyde (Retinal)IBA 10/2008
1	myosin-binding protein CIBA 08/2008
1	VaccinesIBA 05/2008
1	Myelin Basic ProteinIBA 05/2008

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2007
1	Subcutaneous Injections 06/2013